Clinical Pharmacology and Anesthesia Characteristics
Physically, halothane is a colorless, transparent, and volatile liquid with a characteristic odor. A major advantage is that its vapors are completely non-irritating to the respiratory tract—a critical factor for a smooth induction of anesthesia.
The drug has high anesthetic potency and excellent controllability. It has a sufficient therapeutic index, providing a safe margin between effective and toxic doses. The excitement stage is virtually absent when using halothane.
However, using the drug as a single agent (mono-anesthesia) has significant drawbacks: it provides weak muscle relaxation and insufficient analgesia compared to, for example, ether. To counteract these disadvantages, halothane is used as part of balanced anesthesia:
- With nitrous oxide — for a potent analgesic effect.
- With neuromuscular blockers (curare-like agents) — for adequate skeletal muscle relaxation.
This combination allows the drug to be used for a wide range of surgical interventions, including complex major abdominal and thoracic surgeries.
Cardiovascular Effects
The hemodynamic effects of halothane require heightened vigilance from the anesthesiologist. The drug decreases myocardial contractility and provokes bradycardia, driven by stimulation of the vagus nerve center.
A characteristic effect is hypotension (decreased blood pressure), which develops through three parallel mechanisms:
- Depression of the vasomotor center.
- Ganglionic blockade (at the level of sympathetic ganglia).
- Direct myotropic relaxant effect on the vascular wall.
Because of this, halothane potentiates the effects of any hypotensive agents (including diuretics, diazoxide, $\beta$-blockers, and ganglionic blockers).
A critically important property: halothane sensitizes the myocardium, drastically increasing its sensitivity to catecholamines (epinephrine and norepinephrine). Administering epinephrine to a patient under halothane anesthesia inevitably triggers severe cardiac rhythm disturbances. Therefore, phenylephrine is used exclusively to raise blood pressure in the operating room.
Toxicity and Malignant Hyperthermia
Halothane exhibits significant organ toxicity. Its metabolism yields toxic metabolites responsible for the drug's hepatotoxicity. For this reason, its use is discouraged in patients with liver disease. A potential nephrotoxic effect on the kidneys is also noted.
The most life-threatening complication of halothane anesthesia is malignant hyperthermia.
- Trigger: The condition is precipitated by the concurrent administration of halothane and the depolarizing neuromuscular blocker succinylcholine.
- Pathogenesis: A massive, uncontrolled release of $Ca^{2+}$ ions occurs from the sarcoplasmic reticulum into the myocyte cytoplasm. This causes a total skeletal muscle spasm and, consequently, a sharp rise in body temperature up to 42–43 °C.
- Treatment: The only effective specific antidote is dantrolene, a drug that specifically blocks calcium release from the sarcoplasmic reticulum.